DRKS00028899尚未招募不适用
Pilot study: CD40L concentration during ECLS for analysis of platelet function
niversitätsklinikum Gießen und Marburg0 个研究点目标入组 15 人开始时间: 2022年7月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •ECLS support
排除标准
- •Additional mechanical circulatory support (CPB, IABP, VAD); Impella are allowed
- •Heparin-induced thrombocytopenia Typ II
- •less than two measurements possible
- •participation is medically not possible
- •termination of the whole study
研究者
相似试验
已完成
1 期
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus ErythematousSystemic Lupus ErythematousNCT02320357University Hospital, Bordeaux18
已完成
1 期
Measurement of serum soluble CD4 levels in patients with external anogenital warts before and after intralesional injection of tuberculin purified protein derivativeUrological and Genital DiseasesPACTR202006534973105Mohamed Azab49
已完成
1 期
A Phase I/ II Clinical Trial: Autologous CD34+ Cell Transplantation for Bone and Vascular Healing in Patients with Non-Union Fractureon-Union FractureJPRN-UMIN000002993Ryosuke Kuroda, M.D., Ph.D.17
进行中（未招募）
不适用
Offene Phase IIIb Studie zur Elimination von CD4+CD25+ regulatorischen T-Zellen bei Patienten mit fortgeschrittenem HCC durch die Gabe von CyclophosphamidEUCTR2006-002546-11-DEMedizinische Hochschule Hannover
进行中（未招募）
不适用
An open-label study of leukocyte counts in the cerebrospinal fluid and blood of subjects with relapsing forms of multiple sclerosis following treatment with firategrastEUCTR2006-007057-42-SEGlaxoSmithKline Research & Development Ltd45